185 related articles for article (PubMed ID: 21049561)
1. Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery.
Xu LB; Wang J; Liu C; Pang HW; Chen YJ; Ou QJ; Chen JS
World J Gastroenterol; 2010 Nov; 16(41):5257-62. PubMed ID: 21049561
[TBL] [Abstract][Full Text] [Related]
2. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.
Lu W; Dong J; Huang Z; Guo D; Liu Y; Shi S
J Gastroenterol Hepatol; 2008 Dec; 23(12):1874-8. PubMed ID: 18752560
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the Predictive Values of Eight Staging Systems for Primary Liver Cancer in Prognosis of Combined Hepatocellular-cholangiocellular Carcinoma Patients after Surgery].
Li H; Wang XT; Zhang AQ; Meng XF; Yu Q; Lü WP; Duan WD; Dong JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):175-81. PubMed ID: 27181894
[TBL] [Abstract][Full Text] [Related]
4. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
Chen LJ; Chang YJ; Chang YJ
Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
[TBL] [Abstract][Full Text] [Related]
5. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
[TBL] [Abstract][Full Text] [Related]
7. Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.
Liu C; Duan LG; Lu WS; Yan LN; Xiao GQ; Jiang L; Yang J; Yang JY
PLoS One; 2014; 9(8):e103228. PubMed ID: 25133493
[TBL] [Abstract][Full Text] [Related]
8. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
Li JW; Goh BG; Chang PE; Tan CK
World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
[TBL] [Abstract][Full Text] [Related]
9. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM; Sinn DH; Jung SH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2016 Oct; 36(10):1490-7. PubMed ID: 26936471
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of different clinical staging systems for hepatocellular carcinoma].
Qu Q; Rui JA; Wang SB; Chen SG; Zhou L; Han K; Wei X; Zhang N; Zhao HT; Cheng EC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):155-8. PubMed ID: 16750027
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.
Chan AC; Fan ST; Poon RT; Cheung TT; Chok KS; Chan SC; Lo CM
HPB (Oxford); 2013 Jun; 15(6):439-48. PubMed ID: 23659567
[TBL] [Abstract][Full Text] [Related]
13. [Evaluations of seven different clinical staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection].
Zhao J; Yan T; Huang Z; Bi X; Zhao H; Zhou J; Li Z; Li Y; Li C; Cai J
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):903-7. PubMed ID: 24854909
[TBL] [Abstract][Full Text] [Related]
14. Validation and ranking of seven staging systems of hepatocellular carcinoma.
Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
[TBL] [Abstract][Full Text] [Related]
15. Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatment.
Xia F; Huang Z; Zhang Q; Ndhlovu E; Zhang M; Chen X; Chen Y; Zhang B; Zhu P
Eur J Surg Oncol; 2022 Sep; 48(9):2014-2022. PubMed ID: 35595579
[TBL] [Abstract][Full Text] [Related]
16. Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms.
Lee YS; Seo YS; Kim JH; Lee J; Kim HR; Yoo YJ; Kim TS; Kang SH; Suh SJ; Joo MK; Jung YK; Lee BJ; Yim HJ; Yeon JE; Kim JS; Park JJ; Um SH; Bak YT; Byun KS
Gut Liver; 2018 Jan; 12(1):94-101. PubMed ID: 28873509
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
18. A proposed modification for the Barcelona Clinic Liver Cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma.
Lu WP; Tang HW; Yang ZY; Jiang K; Chen YL; Lu SC
Am J Surg; 2020 Oct; 220(4):965-971. PubMed ID: 32336518
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
[TBL] [Abstract][Full Text] [Related]
20. Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy.
Qiao G; Cucchetti A; Li J; Cescon M; Ercolani G; Liu G; Pinna AD; Li L; Shen F; Ren J
Oncotarget; 2016 May; 7(21):30408-19. PubMed ID: 27007152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
